Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Estimating the cost-effectiveness of needle-syringe programs in Australia.

Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP.

AIDS. 2012 Nov 13;26(17):2201-10. doi: 10.1097/QAD.0b013e3283578b5d.

PMID:
22914579
2.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
3.

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H.

BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53. Review.

4.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA.

Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26. Review.

PMID:
20189375
5.

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.

Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC.

AIDS Behav. 2013 Nov;17(9):2878-92. doi: 10.1007/s10461-013-0593-y. Review.

PMID:
23975473
6.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
7.

The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.

Islam M, Wodak A, Conigrave KM.

Int J Drug Policy. 2008 Dec;19(6):436-41. Epub 2007 Sep 4. Review.

PMID:
17766100
8.

[The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].

Takács IG, Demetrovics Z.

Psychiatr Hung. 2009;24(4):264-81. Review. Hungarian.

PMID:
19949245
9.
10.
11.

The role of needle exchange programs in HIV prevention.

Vlahov D, Junge B.

Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

12.

[Intravenous drug use and the spread of HIV; an international perspective].

Meijerink H, van Crevel R, van der Ven AJ.

Ned Tijdschr Geneeskd. 2013;157(21):A5690. Review. Dutch.

PMID:
23693006
13.

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpub/ckp001. Epub 2009 Feb 5. Review.

14.

Epidemiology of hepatitis C virus infection in Australia.

Dore GJ, Law M, MacDonald M, Kaldor JM.

J Clin Virol. 2003 Feb;26(2):171-84. Review.

PMID:
12600649
15.

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D.

BMC Public Health. 2010 Nov 23;10:721. doi: 10.1186/1471-2458-10-721. Review.

16.

Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries.

Zule WA, Cross HE, Stover J, Pretorius C.

Int J Drug Policy. 2013 Jan;24(1):1-7. doi: 10.1016/j.drugpo.2012.07.002. Epub 2012 Aug 10. Review.

PMID:
22884539
17.

[Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].

Gyarmathy VA, Rácz J.

Orv Hetil. 2011 Jan 23;152(4):124-30. doi: 10.1556/OH.2011.29019. Review. Hungarian.

PMID:
21224188
18.

Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial.

Fischer B, Rehm J, Kim G, Robins A.

Can J Public Health. 2002 Sep-Oct;93(5):336-8. Review. No abstract available.

PMID:
12353452
19.

Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.

Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A; Substance Use Scientific Committee of the HIV Prevention Trials Network.

Curr Opin HIV AIDS. 2012 Jul;7(4):320-5. doi: 10.1097/COH.0b013e32835369ad. Review.

20.

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.

Pattanaphesaj J, Teerawattananon Y.

BMC Public Health. 2010 Jul 7;10:401. doi: 10.1186/1471-2458-10-401. Review.

Items per page

Supplemental Content

Write to the Help Desk